Alzheimer’s drugs Market - Global Industry Analysis
Alzheimer’s drugs Market By Drug class (Donepezil, Galantamine, Rivastigmine, Memantine, Others), By Distribution channel (Hospital Pharmacy, Retail Pharmacy, Online Stores, Others), and By Region – Global and Regional Industry Overview, Market Intelligence, Comprehensive Analysis, Historical Data, and Forecasts 2022 – 2028
Published Date: 10-May-2022Pharmaceutical
Category: Report Format : PDF
Report Code: ZMR-2513
Status : Published
The global Alzheimer’s drugs market was worth around USD 6,429.5 billion in 2021 and is estimated to grow to about USD 9276.3 billion by 2028, with a compound annual growth rate (CAGR) of approximately 6.3 percent over the forecast period.